Literature DB >> 8970191

Morphology, function and pathology of follicular dendritic cells.

Y Imal1, M Yamakawa.   

Abstract

The precise ultrastructural morphology and functions in reactive conditions of lymphoid follicles (LF) and dendritic cells, including follicular dendritic cells (FDC) are reviewed; as well as the pathognomonic role of FDC in some disease conditions and finally, the cellular origin of FDC. In reactive conditions, FDC in each of the five follicular zones have distinct ultrastructural features, reflecting the different three-dimensional structures and functions of these zones. The FDC framework may be supported by some characteristic factors, including desmosome-like junctions between FDC and the expression of fibronectin and laminin receptors and caldesmon on FDC. FDC, especially in the light zone, express various cytokine receptors, but produce only one cytokine, TGF-beta. The outer zone may not only be a cellular pathway in the LF, but may also provide a site for germinal center B cell proliferation, and the FDC-lymphocyte cluster is not the site of germinal center B cell division. In patients with auto-immune diseases, such as Hashimoto's thyroiditis and rheumatoid arthritis, FDC may be in a hyperfunctional state, whereas those in patients with immunosuppressive disorders, such as Kimura's disease and AIDS, may be in a dysfunctional state. FDC may be derived from fibroblastic reticulum cells in lymphatic tissues rather than in bone marrow cells. The data discussed in this review provide fascinating insight into the roles of FDC, which are intimately related to the migration, proliferation, cell selection and differentiation of B cells in secondary LF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970191     DOI: 10.1111/j.1440-1827.1996.tb03555.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  23 in total

1.  Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; I Zaitsev; P Koni; Z Y Lu; R A Flavell; W Fritch
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway.

Authors:  Jennifer L Gommerman; Fabienne Mackay; Elina Donskoy; Werner Meier; Pauline Martin; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study.

Authors:  Yasuhiro Horiuchi; Junichi Hakugawa; Kazuhiro Shimizu; Ichiro Katayama; Tomayoshi Hayashi; Masahiro Kikuchi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

Review 4.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function.

Authors:  Christopher D C Allen; Jason G Cyster
Journal:  Semin Immunol       Date:  2008-02-07       Impact factor: 11.130

5.  Immunohistochemical organization patterns of the follicular dendritic cells, myofibroblasts and macrophages in the human spleen--new considerations on the pathological diagnosis of splenectomy pieces.

Authors:  Pablo Guisado Vasco; José L Villar Rodríguez; José Ibañez Martínez; Ricardo González Cámpora; Hugo Galera Davidson
Journal:  Int J Clin Exp Pathol       Date:  2009-12-10

6.  Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Authors:  G H MacDonald; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Tonsillar CD4+FOXP3+ T-regulatory cell dynamics in primary EBV infection.

Authors:  Yen-Hung Chow; Hsuen-Wen Chang; Raymond Sia; Pele Chong; Charles Sia
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

8.  Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interaction.

Authors:  M Fujiwara; R Tsunoda; S Shigeta; T Yokota; M Baba
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

9.  Platelet-activating factor antagonists decrease follicular dendritic-cell stimulation of human B lymphocytes.

Authors:  Isaac Halickman; Yolande Bastien; Qianli Zhuang; Monty B Mazer; Baruch Toledano; Bruce D Mazer
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

10.  IgM expression in paraffin sections distinguishes follicular lymphoma from reactive follicular hyperplasia.

Authors:  Yuanyuan Zheng; Xiaoge Zhou; Jianlan Xie; Hong Zhu; Shuhong Zhang; Yanning Zhang; Xuejing Wei; Bing Yue
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.